Skip to Main Content

Paper Details

Rare germline copy number variants (CNVs) and breast cancer risk.
Commun Biol
7
2022
ATM, BRCA1, BRCA2, CHEK2, CNVs, Germline copy number variants, breast cancer, common susceptibility loci, deletion regions, duplication regions, exonic, genes, germline copy number variants, human, human genome, known genes, non-coding CNVs, non-coding regions, rare CNVs, susceptibility genes
Author NameAffiliation
Jonathan TyrerUniversity of Cambridge
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Sabine BehrensGerman Cancer Research Center (DKFZ)
Javier Ben??tez
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Georgia Chenevix-TrenchQIMR Berghofer Medical Research Institute
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Laure Dossus
Peter A FaschingComprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU)
Peter A FaschingDavid Geffen School of Medicine, University of California at Los Angeles
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D FigueroaThe University of Edinburgh
Jonine D FigueroaThe University of Edinburgh
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Graham G Giles
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Graham G GilesThe University of Melbourne
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Per HallKarolinska Institutet
Per Hall
Esther M JohnStanford University School of Medicine
Esther M JohnStanford Cancer Institute, Stanford University School of Medicine
Rudolf KaaksGerman Cancer Research Center (DKFZ)
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Vessela N KristensenOslo University Hospital and University of Oslo
Vessela N KristensenUniversity of Oslo
James V Lacey
James V LaceyCity of Hope Comprehensive Cancer Center
James V Lacey
James V LaceyCity of Hope Comprehensive Cancer Center
Diether LambrechtsVIB Center for Cancer Biology
  • 1 - 50

Datasets